SpyGlass Pharma SGP
NASDAQ SGP
$33.90 -0.28 (-0.80%)
As of: Nov 11, 2026 · 11:48 AM EST

SpyGlass Pharma (SGP) Change in Account Payables (2025 - 2026)

Updated

SpyGlass Pharma (SGP) posted Change in Account Payables of $549,000 for FY2025, down 59.0% from $1.34 million in FY2024.

Analysis

SpyGlass Pharma (SGP) Change in Account Payables (2025 - 2026) Analysis & Trends

  • Business Quant data shows SGP's Change in Account Payables at $1.34 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 SpyGlass Pharma 1.14 Bn 534.30 Mn - 764,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 764,000.00
Mar 31, 2026 953,000.00
Jun 30, 2025 1.19 Mn
Mar 31, 2025 -372,000.00
API Access

SpyGlass Pharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SGP&period=max&api_key=YOUR_API_KEY